KMT Set7/9 affects genotoxic stress response via the Mdm2 axis

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• Genotoxic stress from anti-cancer drugs causes DNA breaks and genome instability.
• DNA double-strand breaks activate the ATM kinase signaling pathway, triggering cell cycle arrest and DNA repair.
• Histone modifications and signaling pathways influence cellular sensitivity to genotoxic stress.

Purpose of the Study:

• To investigate the role of lysine-specific methyltransferase (KMT) Set7/9 in DNA damage response (DDR) and repair.
• To determine if Set7/9 regulates the expression of the E3 ubiquitin ligase Mdm2.
• To explore the clinical significance of Set7/9 and Mdm2 expression in cancer patient survival.

Main Methods:

• Experimental approaches to assess Set7/9's effect on DDR and DNA repair.
• Co-immunoprecipitation to confirm physical interaction between Set7/9 and Mdm2.
• Analysis of cancer cell line survival under genotoxic stress with varying Set7/9 and Mdm2 levels.
• Bioinformatics analysis of patient data correlating Set7/9 and Mdm2 expression with survival outcomes.

Main Results:

• Set7/9 influences DNA damage response and repair, partly by regulating Mdm2 expression.
• Set7/9 physically interacts with Mdm2.
• Cancer cell lines with inverse Set7/9 and Mdm2 expression showed reduced survival under genotoxic stress.
• Bioinformatics data indicated that high Mdm2 and low Set7/9 expression in cancer patients is linked to poor survival.

Conclusions:

• Set7/9 plays a role in DNA damage response and repair through Mdm2 regulation.
• The inverse relationship between Set7/9 and Mdm2 expression affects cancer cell survival and patient prognosis.
• Targeting Set7/9 or Mdm2 could be a potential therapeutic strategy for improving cancer patient outcomes.